Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,575 | -58,630 | -36,200 | -24,571 | -10,628 |
| Depreciation Amortization | 638 | 2,140 | 1,492 | 1,069 | 432 |
| Accounts receivable | -137 | 75 | -443 | -536 | -12 |
| Accounts payable and accrued liabilities | 3,416 | 1,412 | 991 | 1,312 | -610 |
| Other Working Capital | -1,922 | 5,005 | 865 | 631 | -863 |
| Other Operating Activity | -3,620 | 14,582 | 8,799 | 7,376 | 4,659 |
| Operating Cash Flow | $-24,200 | $-35,416 | $-24,497 | $-14,720 | $-7,022 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,055 | -34,774 | -39,775 | -41,355 | -15,029 |
| PPE Investments | -554 | -1,707 | -1,252 | -608 | -116 |
| Net Acquisitions | -7,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4,500 | $-36,482 | $-41,027 | $-41,963 | $-15,146 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -103 | -225 | -257 | -204 | -55 |
| Common Stock Issued | 284 | 185,520 | 185,016 | 180,621 | 62,822 |
| Financing Cash Flow | $180 | $185,294 | $184,759 | $180,417 | $62,767 |
| Beginning Cash Position | 132,511 | 19,114 | 19,114 | 19,114 | 19,114 |
| End Cash Position | 103,991 | 132,511 | 138,350 | 142,848 | 59,713 |
| Net Cash Flow | $-28,519 | $113,396 | $119,235 | $123,733 | $40,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,200 | -35,416 | -24,497 | -14,720 | -7,022 |
| Capital Expenditure | -555 | -1,717 | -1,252 | -608 | -116 |
| Free Cash Flow | -24,755 | -37,134 | -25,749 | -15,328 | -7,139 |